1. Home
  2. CADL vs CRON Comparison

CADL vs CRON Comparison

Compare CADL & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$12.87

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Cronos Group Inc.

CRON

Cronos Group Inc.

HOLD

Current Price

$3.39

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
CRON
Founded
1999
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
CADL
CRON
Price
$12.87
$3.39
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$19.00
N/A
AVG Volume (30 Days)
1.2M
1.7M
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
58.62
N/A
EPS
N/A
0.12
Revenue
$125,000.00
$146,587,000.00
Revenue This Year
N/A
$26.34
Revenue Next Year
N/A
$15.53
P/E Ratio
N/A
$28.17
Revenue Growth
N/A
24.63
52 Week Low
$4.35
$2.28
52 Week High
$14.00
$3.61

Technical Indicators

Market Signals
Indicator
CADL
CRON
Relative Strength Index (RSI) 59.95 63.26
Support Level $4.84 $2.50
Resistance Level N/A $3.43
Average True Range (ATR) 0.89 0.12
MACD 0.01 0.00
Stochastic Oscillator 68.23 59.53

Price Performance

Historical Comparison
CADL
CRON

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About CRON Cronos Group Inc.

Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.

Share on Social Networks: